Report Detail

Other Global Blood Transfusion Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4600292
  • |
  • 02 July, 2024
  • |
  • Global
  • |
  • 113 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Blood Transfusion Diagnostics market size was valued at USD 3122.6 million in 2023 and is forecast to a readjusted size of USD 4276.1 million by 2030 with a CAGR of 4.6% during review period.
Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Blood Transfusion Diagnostics industry chain, the market status of Hospitals (ELISA, NAT), Clinics (ELISA, NAT), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Transfusion Diagnostics.
Regionally, the report analyzes the Blood Transfusion Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Blood Transfusion Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Blood Transfusion Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Blood Transfusion Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ELISA, NAT).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Blood Transfusion Diagnostics market.
Regional Analysis: The report involves examining the Blood Transfusion Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Blood Transfusion Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Blood Transfusion Diagnostics:
Company Analysis: Report covers individual Blood Transfusion Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Blood Transfusion Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Blood Transfusion Diagnostics. It assesses the current state, advancements, and potential future developments in Blood Transfusion Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Blood Transfusion Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Blood Transfusion Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology
Market segment by Application
Hospitals
Clinics
Blood Banks
Laboratories
Other
Market segment by players, this report covers
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Transfusion Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Transfusion Diagnostics, with revenue, gross margin and global market share of Blood Transfusion Diagnostics from 2019 to 2024.
Chapter 3, the Blood Transfusion Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Blood Transfusion Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Transfusion Diagnostics.
Chapter 13, to describe Blood Transfusion Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Blood Transfusion Diagnostics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Blood Transfusion Diagnostics by Type
    • 1.3.1 Overview: Global Blood Transfusion Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Blood Transfusion Diagnostics Consumption Value Market Share by Type in 2023
    • 1.3.3 ELISA
    • 1.3.4 NAT
    • 1.3.5 Western Blot Assays
    • 1.3.6 Fluorescence Assay
    • 1.3.7 Other Technology
  • 1.4 Global Blood Transfusion Diagnostics Market by Application
    • 1.4.1 Overview: Global Blood Transfusion Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Blood Banks
    • 1.4.5 Laboratories
    • 1.4.6 Other
  • 1.5 Global Blood Transfusion Diagnostics Market Size & Forecast
  • 1.6 Global Blood Transfusion Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Blood Transfusion Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Blood Transfusion Diagnostics Market Size by Region, (2019-2030)
    • 1.6.3 North America Blood Transfusion Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Blood Transfusion Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Blood Transfusion Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Blood Transfusion Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Blood Transfusion Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Grifols
    • 2.1.1 Grifols Details
    • 2.1.2 Grifols Major Business
    • 2.1.3 Grifols Blood Transfusion Diagnostics Product and Solutions
    • 2.1.4 Grifols Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Grifols Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Blood Transfusion Diagnostics Product and Solutions
    • 2.3.4 Roche Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 bioMérieux
    • 2.4.1 bioMérieux Details
    • 2.4.2 bioMérieux Major Business
    • 2.4.3 bioMérieux Blood Transfusion Diagnostics Product and Solutions
    • 2.4.4 bioMérieux Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 bioMérieux Recent Developments and Future Plans
  • 2.5 Bio-Rad
    • 2.5.1 Bio-Rad Details
    • 2.5.2 Bio-Rad Major Business
    • 2.5.3 Bio-Rad Blood Transfusion Diagnostics Product and Solutions
    • 2.5.4 Bio-Rad Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bio-Rad Recent Developments and Future Plans
  • 2.6 Ortho Clinical Diagnostics
    • 2.6.1 Ortho Clinical Diagnostics Details
    • 2.6.2 Ortho Clinical Diagnostics Major Business
    • 2.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Product and Solutions
    • 2.6.4 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
  • 2.7 Becton Dickinson
    • 2.7.1 Becton Dickinson Details
    • 2.7.2 Becton Dickinson Major Business
    • 2.7.3 Becton Dickinson Blood Transfusion Diagnostics Product and Solutions
    • 2.7.4 Becton Dickinson Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Becton Dickinson Recent Developments and Future Plans
  • 2.8 Fujirebio
    • 2.8.1 Fujirebio Details
    • 2.8.2 Fujirebio Major Business
    • 2.8.3 Fujirebio Blood Transfusion Diagnostics Product and Solutions
    • 2.8.4 Fujirebio Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Fujirebio Recent Developments and Future Plans
  • 2.9 DiaSorin(American Standard Companies)
    • 2.9.1 DiaSorin(American Standard Companies) Details
    • 2.9.2 DiaSorin(American Standard Companies) Major Business
    • 2.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Product and Solutions
    • 2.9.4 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 DiaSorin(American Standard Companies) Recent Developments and Future Plans
  • 2.10 Beckman Coulter
    • 2.10.1 Beckman Coulter Details
    • 2.10.2 Beckman Coulter Major Business
    • 2.10.3 Beckman Coulter Blood Transfusion Diagnostics Product and Solutions
    • 2.10.4 Beckman Coulter Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Beckman Coulter Recent Developments and Future Plans
  • 2.11 Diagast
    • 2.11.1 Diagast Details
    • 2.11.2 Diagast Major Business
    • 2.11.3 Diagast Blood Transfusion Diagnostics Product and Solutions
    • 2.11.4 Diagast Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Diagast Recent Developments and Future Plans
  • 2.12 Abbott
    • 2.12.1 Abbott Details
    • 2.12.2 Abbott Major Business
    • 2.12.3 Abbott Blood Transfusion Diagnostics Product and Solutions
    • 2.12.4 Abbott Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Abbott Recent Developments and Future Plans
  • 2.13 BAG Health Care
    • 2.13.1 BAG Health Care Details
    • 2.13.2 BAG Health Care Major Business
    • 2.13.3 BAG Health Care Blood Transfusion Diagnostics Product and Solutions
    • 2.13.4 BAG Health Care Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 BAG Health Care Recent Developments and Future Plans
  • 2.14 Quidel
    • 2.14.1 Quidel Details
    • 2.14.2 Quidel Major Business
    • 2.14.3 Quidel Blood Transfusion Diagnostics Product and Solutions
    • 2.14.4 Quidel Blood Transfusion Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Quidel Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Blood Transfusion Diagnostics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Blood Transfusion Diagnostics by Company Revenue
    • 3.2.2 Top 3 Blood Transfusion Diagnostics Players Market Share in 2023
    • 3.2.3 Top 6 Blood Transfusion Diagnostics Players Market Share in 2023
  • 3.3 Blood Transfusion Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Blood Transfusion Diagnostics Market: Region Footprint
    • 3.3.2 Blood Transfusion Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Blood Transfusion Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Blood Transfusion Diagnostics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Blood Transfusion Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Blood Transfusion Diagnostics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Blood Transfusion Diagnostics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Blood Transfusion Diagnostics Consumption Value by Type (2019-2030)
  • 6.2 North America Blood Transfusion Diagnostics Consumption Value by Application (2019-2030)
  • 6.3 North America Blood Transfusion Diagnostics Market Size by Country
    • 6.3.1 North America Blood Transfusion Diagnostics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Blood Transfusion Diagnostics Consumption Value by Type (2019-2030)
  • 7.2 Europe Blood Transfusion Diagnostics Consumption Value by Application (2019-2030)
  • 7.3 Europe Blood Transfusion Diagnostics Market Size by Country
    • 7.3.1 Europe Blood Transfusion Diagnostics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.3 France Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Blood Transfusion Diagnostics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Blood Transfusion Diagnostics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Blood Transfusion Diagnostics Consumption Value by Region (2019-2030)
    • 8.3.2 China Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.5 India Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Blood Transfusion Diagnostics Consumption Value by Type (2019-2030)
  • 9.2 South America Blood Transfusion Diagnostics Consumption Value by Application (2019-2030)
  • 9.3 South America Blood Transfusion Diagnostics Market Size by Country
    • 9.3.1 South America Blood Transfusion Diagnostics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Blood Transfusion Diagnostics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Blood Transfusion Diagnostics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Blood Transfusion Diagnostics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Blood Transfusion Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Blood Transfusion Diagnostics Market Drivers
  • 11.2 Blood Transfusion Diagnostics Market Restraints
  • 11.3 Blood Transfusion Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Blood Transfusion Diagnostics Industry Chain
  • 12.2 Blood Transfusion Diagnostics Upstream Analysis
  • 12.3 Blood Transfusion Diagnostics Midstream Analysis
  • 12.4 Blood Transfusion Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Blood Transfusion Diagnostics. Industry analysis & Market Report on Blood Transfusion Diagnostics is a syndicated market report, published as Global Blood Transfusion Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Blood Transfusion Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,623.92
    3,935.88
    5,247.84
    3,121.56
    4,682.34
    6,243.12
    497,048.40
    745,572.60
    994,096.80
    291,136.80
    436,705.20
    582,273.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report